로그인

Laura Heiser

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

BIOGRAPHY

Laura Heiser has not added Biography.

If you are Laura Heiser and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer.

Molecular cancer therapeutics Dec, 2017 | Pubmed ID: 28958991

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer.

Scientific reports Mar, 2019 | Pubmed ID: 30846826

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer.

Oncogene Apr, 2019 | Pubmed ID: 30996246

INSTITUTIONS

Oregon Health and Science University

JOVE ARTICLES

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Rebecca Smith¹,

Kaylyn Devlin¹,

David Kilburn¹,

Sean Gross¹,

Damir Sudar²,

Elmar Bucher¹,

Michel Nederlof²,

Mark Dane¹,

Joe W. Gray¹,

Laura Heiser¹,

James E. Korkola¹

¹Department of Biomedical Engineering, Knight Cancer Institute, Oregon Health and Science University,

², Quantitative Imaging Systems LLC

Cancer Research

개인 정보 보호

이용 약관

정책

연락처

사서에게 추천하기

JoVE 뉴스레터

연구

JoVE Journal
연구 방법 컬렉션
JoVE Encyclopedia of Experiments
아카이브

교육

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
교수 리소스 센터
Faculty Site

저자

개요
간행과정
편집 위원회
범위 및 정책
Peer Review
자주하는 질문
제출

사서

개요
추천의 글
구독
액세스
리소스
라이브러리 자문 위원회
자주하는 질문

JoVE 소개

개요
리더십
블로그
JoVE Help Center

Laura Heiser

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biomedical Engineering,Knight Cancer Institute,Department of Biomedical Engineering, Knight Cancer Institute

Oregon Health and Science University

Using Microarrays to Interrogate Microenvironmental Impact on Cellular Phenotypes in Cancer

Department of Biomedical Engineering,
Knight Cancer Institute,
Department of Biomedical Engineering, Knight Cancer Institute